$8.84 -$0.07 (-0.8%)

04:00 PM EST on 11/21/19

Lannett Company, Inc. (NYSE:LCI)

CAPS Rating: 4 out of 5

The Company develops, manufactures, markets and distributes generic versions of pharmaceutical products.

Current Price $8.84 Mkt Cap $343.3M
Open $8.85 P/E Ratio 103.62
Prev. Close $8.91 Div. (Yield) $0.00 (0.0%)
Daily Range $8.72 - $9.05 Volume 187,045
52-Wk Range $4.81 - $15.37 Avg. Daily Vol. 1,248,132

Caps

How do you think NYSE:LCI will perform against the market?

Add Stock to CAPS Watchlist

All Players

164 Outperform
18 Underperform
 

All-Star Players

24 Outperform
8 Underperform
 

Wall Street

1 Outperform
1 Underperform
 

Top NYSE:LCI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

TMFCoolGuy (72.67)
Submitted January 29, 2015

Lannett Company manufactures and distributes generic pharmaceutical products in tablets, capsule and oral liquid forms. The company has more than 40 marketed products across several therapeutic areas, but is strategically targeting its capabilities… More

FinancialModeler (26.23)
Submitted March 11, 2009

Whoever said this stock is under valued needs to learn what value really is. LCI has a PE ratio over 100. The stock trades within 10% of its 52 week high. Returns on assets, equity, and capital is almost nothing. No dividend. Less than 2% profit… More

NYSE:LCI VS S&P 500 (SPY)

Fools bullish on NYSE:LCI are also bullish on:

Fools bearish on NYSE:LCI are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about LCI.

Recs

0
Member Avatar TMFBigFrog (92.88) Submitted: 6/23/2018 8:04:27 PM : Outperform Start Price: $14.05 NYSE:LCI Score: -50.58

Stock trading near a 5-year low as fears of a price war spook the market.

Recs

0
Member Avatar timeno (< 20) Submitted: 1/3/2017 4:14:23 PM : Outperform Start Price: $22.55 NYSE:LCI Score: -98.35

Clean up of the recent DoJ investigations on price fixing will allow this company to rebound.

Recs

0
Member Avatar mjtri (45.93) Submitted: 7/6/2016 10:48:18 PM : Outperform Start Price: $25.12 NYSE:LCI Score: -112.68

PE of 7 and it's growing. Biomedical has probably hit bottom. Issues behind stock tanking are being addressed. Maybe not the best company in the world, but how good to you need to be with sales growth of 41% expected this quarter and a PE of 7?

Leaderboard

Find the members with the highest scoring picks in LCI.

Score Leader

Chemnerd

Chemnerd (57.75) Score: +1,055.75

The Score Leader is the player with the highest score across all their picks in LCI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
FinancialModeler 26.23 3/11/2009 Underperform NS $5.30 +66.79% +334.77% +267.98 2 Comments
GlugGlugGlug < 20 7/23/2009 Underperform 5Y $9.56 -7.53% +218.63% +226.16 0 Comment
VoodooEconomist 43.36 4/14/2009 Underperform 3W $5.79 +52.68% +270.70% +218.02 1 Comment
anticitradeshort 31.32 4/20/2009 Underperform NS $5.89 +50.08% +266.58% +216.49 0 Comment
Snadroj 88.82 3/25/2014 Underperform 3Y $36.23 -75.60% +66.52% +142.12 0 Comment
armycommando 68.75 4/16/2014 Underperform 5Y $31.21 -71.68% +67.33% +139.00 0 Comment
CocaineOrStock 99.28 7/15/2014 Underperform 5Y $47.10 -81.23% +57.31% +138.54 0 Comment
Rollme < 20 10/4/2013 Underperform 5Y $18.13 -51.25% +84.56% +135.81 0 Comment
Hendrickson71 < 20 11/11/2015 Underperform 3W $35.45 -75.06% +49.37% +124.43 1 Comment
rothenbr 85.50 8/22/2016 Underperform 3Y $30.90 -71.39% +42.19% +113.58 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for LCI.